| Hematology |
| WBC | 18,000 | /μL |
| Neut | 92 | % |
| Ly | 3 | % |
| RBC | 268 × 104 | /μL |
| Hemoglobin | 7.9 | g/dL |
| Platelet | 19,000 | /μL |
| Fragmentation | + | |
| Haptoglobin | < 10 | mg/dL |
| ADAMTS13 |
| Activity | 17.8 | % |
| Inhibitor | – | |
| Direct Coombs’ test | – | |
| Indirect Coombs’ test | – | |
| Biochemistry |
| TP | 6.0 | g/dL |
| Alb | 2.0 | g/dL |
| BUN | 32 | mg/dL |
| Cre | 0.6 | mg/dL |
| Na | 120 | mEq/L |
| K | 6.1 | mEq/L |
| Cl | 89 | mEq/L |
| LDH | 1942 | IU/L |
| AST | 260 | IU/L |
| ALT | 138 | IU/L |
| CK | 9823 | IU/L |
| Myoglobin (≦ 154.9) | 307.3 | ng/mL |
| Ferritin (12–60) | 876 | ng/mL |
| Serology |
| CRP | 0.27 | mg/dL |
| C3 | 65 | mg/dL |
| C4 | 14 | mg/dL |
| CH50 | 32.6 | U/mL |
| ANA | < 40x | |
| Anti-DNA Ab | – | |
| Anti-Jo-1 Ab | – | |
| Anti-ARS Ab | PL-12 + | |
| Anti-factor H Ab | – | |
| Coagulation |
| PT-INR | 1.07 | |
| APTT (24–40) | 39.3 | sec |
| Fibrinogen | 252 | mg/dL |
| FDP | 12.4 | μg/mL |
| D-dimer | 5.74 | μg/mL |
| Urinalysis |
| pH | 5.5 | |
| Protein | 1+ | |
| Glucose | – | |
| Occult blood | 2+ | |
| Sediment |
| RBC | 10–19 | /hpf |
| WBC | 1–4 | /hpf |
| Cast | – | |
| Myoglobin (≦ 10) | 110 | ng/mL |
- WBC, leukocytes; RBC, erythrocytes; Neu, neutrophil; Ly, lymphocyte; TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cre, creatinine; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CK, creatine kinase; CRP, C-reactive protein; ANA, anti-nuclear antibody; Ab, antibodies; ARS, aminoacyl-tRNA synthetase; PT, prothrombin time; APTT, activated partial thromboplastin time; FDP, fibrin degradation products; hpf, high-power field
